The Street
  • 5 months ago
TheStreet’s Conway Gittens brings you the biggest news of the day, including what investors are watching and Eli Lilly’s new Alzheimer’s drug gets FDA approval.

Category

🥇
Sports
Transcript
00:00I'm Conway Gittins reporting from the New York Stock Exchange. Here's what we're watching on the street today.
00:04Stocks are coming off a strong session with both the S&P 500 and the Nasdaq clinching new record highs.
00:10Trading activity will be lighter today with markets closing early at 1 p.m. Eastern time for the July 4th holiday.
00:17Wall Street will be back in full swing Friday when the highly anticipated June jobs report is released.
00:23In other news, the Food and Drug Administration has approved Eli Lilly's Alzheimer's treatment.
00:28The FDA unanimously determined that the drug's ability to slow the effects of Alzheimer's outweighed its risks.
00:36Eli Lilly's drug decreased cognitive and functional decline by 35 percent over 18 months compared with a placebo.
00:43The drug, which will be sold under the brand name Kisunla, is for adults with early symptoms of the disease.
00:50After the approval, the co-founder of the Alzheimer's Drug Discovery Foundation said,
00:55This approval marks another step forward in evolving the standard of care for people living with Alzheimer's disease
01:01that will ultimately include an arsenal of novel treatments providing much-needed hope to the Alzheimer's community.
01:08According to the Alzheimer's Association,
01:10roughly 7 million Americans suffer from the disease and it's the fifth leading cause of death for adults over 65.
01:19That'll do it for your daily briefing from the New York Stock Exchange. I'm Conway Gittins with the street.
01:24Thanks for watching.

Recommended

2:02
I
Up next
Medicare enrollees may be getting cheaper medication
The Street
1:04
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
Benzinga
1:48
Obesity drugs might get covered under Medicare and Medicaid
The Street
1:44
Ozempic could help lower the risk of an opioid overdose
The Street
2:17
Biogen Plunges After FDA Says No to Alzheimer's Treatment
The Street
1:32
Taking a multivitamin won’t add years to your life
The Street
1:39
Walgreens to lower prices on thousands of products
The Street
1:56
McDonald’s unveils plans for new value menu
The Street
0:39
FDA Approves Eli Lilly's Alzheimer's Drug, Slowing the Progression of the Brain-Wasting Disease
Benzinga
0:47
Lilly Alzheimer's drug fails in big study
Wibbitz Top Stories
2:04
E. coli outbreak linked to McDonald’s Quarter Pounders
The Street
2:24
Biggest Pharmaceuticals Mergers And Acquisition in History
The Street
2:13
Dow faces 9th straight day in the red
The Street
2:03
Americans are ditching dollar stores
The Street
1:51
Judge strikes down ban on “noncompete” agreements
The Street
2:01
Bed Bath & Beyond is coming back to brick and mortar stores
The Street
1:53
Grocery prices finally start to come down
The Street
1:58
GameStop, AMC make a roaring comeback
The Street
1:30
“Pharmageddon” begins as Walgreens workers walk out
The Street
2:09
Stellantis is closing its Arizona Proving Grounds
The Street
1:58
Nike CEO to retire after four years at the helm
The Street
2:06
Eli Lilly launches lower-cost weight loss drug
The Street
2:02
FTC unveils “click to cancel” rule
The Street
1:53
More affluent Americans are living paycheck to paycheck
The Street
1:51
McDonald’s to invest $1.3 billion in Europe over the next four years
The Street